$41m profit for GSK

 In Australia, NewZealand, Pharmacy
Glaxosmithkline says the local Pharma industry appears to be in a negative cycle, after reporting its 2012 figures earlier this week.

GSK’s 2012 sales in Australia amounted to $1.452 billion, and while sales were up marginally overall, with a 9{845d44a2f09c0018d802e19e78941a85dc2180e4ed7410cee0b34e8cb134ecea} growth in exports to $521 million, the $41m pre-tax profit was lower due to changes in the Pharmaceutical business. Pharmacy Daiy – Read More.


Recent Posts

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.